Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Immuno Diagnostic Oy
OY
Active
Y-tunnus 0499964-0
Kaivokatu 16, 13100
Hämeenlinna
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1983 · 43 years old
— employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Immuno Diagnostic Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
25M
19M
12M
6M
0M
2020: 20M
20M
2020
2021: 18M (-10% vs 2020)
18M
-10%
2021
2022: 12M (-33% vs 2021)
12M
-33%
2022
2024: 10M (-17% vs 2022)
10M
-17%
2024
2025: 5M (-50% vs 2024)
5M
-50%
2025
EBITDA
EUR millions
4M
3M
2M
1M
0M
2020: 3M
3M
2020
2021: 3M (0% vs 2020)
3M
0%
2021
2022: 1M (-67% vs 2021)
1M
-67%
2022
2024: 1M (0% vs 2022)
1M
0%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
EUR thousands
Item
2025
2024
2022
2021
2020
Revenue
4 872
10 161
12 169
18 342
19 745
Staff expenses
−719
−1 834
−2 181
−2 561
−2 761
EBITDA
439
1 060
1 480
3 221
3 466
Depreciation & amort.
−165
−274
−238
−244
−161
EBIT
274
786
1 242
2 977
3 305
Net financials
19
19
−2
0
−1
Profit before tax
294
805
1 240
2 978
3 304
Tax
57
201
261
613
662
Net profit
236
604
980
2 365
2 642
Balance sheet
EUR thousands
Item
2025
2024
2022
2021
2020
Total assets
2 611
4 863
6 554
7 648
8 067
Equity
1 947
2 311
2 237
3 657
3 592
Long-term debt
0
0
122
79
160
Short-term debt
664
2 552
4 196
3 912
4 315
Total debt
664
2 552
4 317
3 991
4 475
Financial ratios
5-year trend
EBITDA margin
9,0 %
This company
15,8 %
Market median
This company
Market median
43% below market
2020
2025
Equity ratio
74,6 %
This company
38,2 %
Market median
This company
Market median
95% above market
2020
2025
Return on equity
12,1 %
This company
18,4 %
Market median
This company
Market median
34% below market
2020
2025
Net profit margin
4,9 %
This company
8,1 %
Market median
This company
Market median
40% below market
2020
2025
Asset turnover
1,87×
This company
1,12×
Market median
This company
Market median
67% above market
2020
2025
Debt / equity
0,34×
This company
0,62×
Market median
This company
Market median
45% below market
2020
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
More on Immuno Diagnostic Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
